Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jonathan W, Dickerson"'
Autor:
Lisa Barbaro, Alice L. Rodriguez, Ashlyn N. Blevins, Jonathan W. Dickerson, Natasha Billard, Olivier Boutaud, Jerri L. Rook, Colleen M. Niswender, P.Jeffrey Conn, Darren W. Engers, Craig W. Lindsley
Publikováno v:
ACS Bio & Med Chem Au, Vol 1, Iss 1, Pp 21-30 (2021)
Externí odkaz:
https://doaj.org/article/a1962d9086d84ecabe40eff8d58cb02f
Autor:
Sichen Chang, Jonathan W. Dickerson, Baker Logan A, Thomas M. Bridges, Craig W. Lindsley, Darren W. Engers, Aidong Qi, Jerri M. Rook, Aaron M. Bender, P. Jeffrey Conn, Katrina A. Bollinger, Colleen M. Niswender, Changho Han, Alice L. Rodriguez, Trever R Carter, Li Peng, Julie L. Engers, Jordan C. O’Neill, Matthew Spock, Katherine J. Watson
Publikováno v:
ACS Med Chem Lett
[Image: see text] Herein, we report the SAR leading to the discovery of VU6028418, a potent M(4) mAChR antagonist with high subtype-selectivity and attractive DMPK properties in vitro and in vivo across multiple species. VU6028418 was subsequently ev
Autor:
Jerri M. Rook, Aaron M. Bender, Colleen M. Niswender, Yuping Donsante, P. Jeffrey Conn, Hyekyung P. Cho, Li Peng, Julie L. Engers, Jonathan W. Dickerson, Thomas M. Bridges, Craig W. Lindsley, Ellen J. Hess, Sichen Chang, Aidong Qi, Weimin Peng, Mark S. Moehle, Jordan C. O’Neill, Daniel J. Foster, Alice L. Rodriguez, Zoey Bryant, Katherine J. Watson, Kaylee J. Stillwell
Publikováno v:
ACS Pharmacology & Translational Science. 4:1306-1321
Nonselective antagonists of muscarinic acetylcholine receptors (mAChRs) that broadly inhibit all five mAChR subtypes provide an efficacious treatment for some movement disorders, including Parkinson's disease and dystonia. Despite their efficacy in t
Autor:
Darren W. Engers, Natasha Billard, Colleen M. Niswender, Ashlyn N. Blevins, Olivier Boutaud, Jonathan W. Dickerson, P. Jeffrey Conn, Jerri L. Rook, Craig W. Lindsley, Alice L. Rodriguez, Lisa Barbaro
Publikováno v:
ACS Bio & Med Chem Au, Vol 1, Iss 1, Pp 21-30 (2021)
Autor:
Aaron M, Bender, Trever R, Carter, Matthew, Spock, Alice L, Rodriguez, Jonathan W, Dickerson, Jerri M, Rook, Sichen, Chang, Aidong, Qi, Christopher C, Presley, Darren W, Engers, Joel M, Harp, Thomas M, Bridges, Colleen M, Niswender, P Jeffrey, Conn, Craig W, Lindsley
Publikováno v:
Bioorganicmedicinal chemistry letters. 56
In this manuscript, we report a series of chiral 6-azaspiro[2.5]octanes and related spirocycles as highly potent and selective antagonists of the muscarinic acetylcholine receptor subtype 4 (mAChR
Autor:
Caitlin N, Kent, Mark G, Fulton, Kaylee J, Stillwell, Jonathan W, Dickerson, Matthew T, Loch, Alice L, Rodriguez, Anna L, Blobaum, Olivier, Boutaud, Jerri L, Rook, Colleen M, Niswender, P Jeffrey, Conn, Craig W, Lindsley
Publikováno v:
Bioorganicmedicinal chemistry letters. 37
A high throughput screen (HTS) identified a novel, but weak (EC
Autor:
Sichen Chang, Ellen J. Hess, Jerri M. Rook, Jonathan W. Dickerson, Colleen M. Niswender, Yuping Donsante, Weimin Peng, Craig W. Lindsley, Li Peng, Julie L. Engers, Thomas M. Bridges, Mark S. Moehle, Daniel J. Foster, P. Jeffrey Conn, Aaron M. Bender, Alice L. Rodriguez, Zoey Bryant, Katherine J. Watson, Jordan C. O’Neill
Non-selective antagonists of muscarinic acetylcholine receptors (mAChRs) that broadly inhibit all five mAChR subtypes provide an efficacious treatment for some movement disorders, including Parkinson disease and dystonia. Despite their efficacy in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2f6ae5b896aa0960348eb4cabab3c6e
https://doi.org/10.1101/2020.10.12.324152
https://doi.org/10.1101/2020.10.12.324152
Autor:
Mark S, Moehle, Aaron M, Bender, Jonathan W, Dickerson, Daniel J, Foster, Aidong, Qi, Hyekyung P, Cho, Yuping, Donsante, Weimin, Peng, Zoey, Bryant, Kaylee J, Stillwell, Thomas M, Bridges, Sichen, Chang, Katherine J, Watson, Jordan C, O'Neill, Julie L, Engers, Li, Peng, Alice L, Rodriguez, Colleen M, Niswender, Craig W, Lindsley, Ellen J, Hess, P Jeffrey, Conn, Jerri M, Rook
Publikováno v:
ACS Pharmacol Transl Sci
[Image: see text] Nonselective antagonists of muscarinic acetylcholine receptors (mAChRs) that broadly inhibit all five mAChR subtypes provide an efficacious treatment for some movement disorders, including Parkinson’s disease and dystonia. Despite
Autor:
Jerri M. Rook, P. Jeffrey Conn, Aidong Qi, Aaron M. Bender, Matthew Spock, Colleen M. Niswender, Thomas M. Bridges, Sichen Chang, Trever R Carter, Craig W. Lindsley, Joel M. Harp, Christopher C Presley, Alice L. Rodriguez, Darren W. Engers, Jonathan W. Dickerson
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 56:128479
In this manuscript, we report a series of chiral 6-azaspiro[2.5]octanes and related spirocycles as highly potent and selective antagonists of the muscarinic acetylcholine receptor subtype 4 (mAChR4). Chiral separation and subsequent X-ray crystallogr
Autor:
Anna L. Blobaum, Jerri M. Rook, Jonathan W. Dickerson, Colleen M. Niswender, Julie L. Engers, Hekyung P Cho, Elizabeth S. Childress, Darren W. Engers, Rory A. Capstick, P. Jeffrey Conn, Craig W. Lindsley, Vincent B. Luscombe, Madeline F. Long
Publikováno v:
ACS Medicinal Chemistry Letters. 9:917-922
[Image: see text] Herein, we report the chemical optimization of a new series of M(1) positive allosteric modulators (PAMs) based on a novel pyrrolo[2,3-b]pyridine core, developed via scaffold hopping and iterative parallel synthesis. The vast majori